Skip to Main Content

Paper Details

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better <i>BRAF</i> Mutated and a Worse <i>KRAS</i> Mutated Subgroup.
Front Oncol
30
2020
BRAF, BRAFmut, CDX2, Caudal-type homeobox 2, KRAS, KRASmut, Metastatic Colorectal Cancer, Patients, mCRC, metastatic colorectal cancer, patients, tumor
Author NameAffiliation
Per-Henrik EdqvistUppsala University
Fredrik Pont??nUppsala University
Fredrik Pont??nUppsala University
Fredrik Pont??nUppsala University
Fredrik Pont??nUppsala University
Bengt GlimeliusUppsala University
  • 1 - 6

Datasets

Release 1.2